Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver.
There is a dire need for curative therapy for primary biliary cholangitis across the world. This is because of the recurring nature of the disease. Currently, the only cure for the condition is a liver transplant. This method of treatment makes it difficult for patients to lead a normal life even with post-surgery treatment. This has resulted in research on stem cell transplantation to replace destroyed cells in the bile duct.
The report details the trend, potential and market size of Primary Biliary Cholangitis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Primary Biliary Cholangitis Therapeuticsmarket, defines the market attractiveness level of Primary Biliary Cholangitis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Primary Biliary Cholangitis Therapeutics industry, describes the types of Primary Biliary Cholangitis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Primary Biliary Cholangitis Therapeutics market and the development prospects and opportunities of Primary Biliary Cholangitis Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Primary Biliary Cholangitis Therapeutics market in Chapter 13.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
Type 1
Type 2
Type 3
By End-User:
Application 1
Application 2
Application 3
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Primary Biliary Cholangitis Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Primary Biliary Cholangitis Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Primary Biliary Cholangitis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Primary Biliary Cholangitis Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Primary Biliary Cholangitis Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Primary Biliary Cholangitis Therapeutics Consumption (2017-2022)
-
7.2 United States Primary Biliary Cholangitis Therapeutics Consumption (2017-2022)
-
7.3 Europe Primary Biliary Cholangitis Therapeutics Consumption (2017-2022)
-
7.4 China Primary Biliary Cholangitis Therapeutics Consumption (2017-2022)
-
7.5 Japan Primary Biliary Cholangitis Therapeutics Consumption (2017-2022)
-
7.6 India Primary Biliary Cholangitis Therapeutics Consumption (2017-2022)
-
7.7 South Korea Primary Biliary Cholangitis Therapeutics Consumption (2017-2022)
8 Region and Country-wise Primary Biliary Cholangitis Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Primary Biliary Cholangitis Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Primary Biliary Cholangitis Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Primary Biliary Cholangitis Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Primary Biliary Cholangitis Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Primary Biliary Cholangitis Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Primary Biliary Cholangitis Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Primary Biliary Cholangitis Therapeutics Consumption Forecast (2022-2028)
9 Global Primary Biliary Cholangitis Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Primary Biliary Cholangitis Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)
-
9.2 Global Primary Biliary Cholangitis Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Application 1 Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Application 2 Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Application 3 Consumption and Growth Rate (2017-2022)
10 Global Primary Biliary Cholangitis Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Primary Biliary Cholangitis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Primary Biliary Cholangitis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Application 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Application 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Application 3 Consumption Forecast and Growth Rate (2022-2028)
11 Global Primary Biliary Cholangitis Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Primary Biliary Cholangitis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Primary Biliary Cholangitis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Primary Biliary Cholangitis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Primary Biliary Cholangitis Therapeutics Market Competitive Analysis
-
14.1 Company 1
-
14.1.1 Company 1 Company Details
-
14.1.2 Company 1 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Company 1 Primary Biliary Cholangitis Therapeutics Product and Service
-
14.2 Company 2
-
14.2.1 Company 2 Company Details
-
14.2.2 Company 2 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Company 2 Primary Biliary Cholangitis Therapeutics Product and Service
-
14.3 Company 3
-
14.3.1 Company 3 Company Details
-
14.3.2 Company 3 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Company 3 Primary Biliary Cholangitis Therapeutics Product and Service
-
14.4 Company 4
-
14.4.1 Company 4 Company Details
-
14.4.2 Company 4 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Company 4 Primary Biliary Cholangitis Therapeutics Product and Service
-
14.5 Company 5
-
14.5.1 Company 5 Company Details
-
14.5.2 Company 5 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Company 5 Primary Biliary Cholangitis Therapeutics Product and Service
-
14.6 Company 6
-
14.6.1 Company 6 Company Details
-
14.6.2 Company 6 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Company 6 Primary Biliary Cholangitis Therapeutics Product and Service
-
14.7 Company 7
-
14.7.1 Company 7 Company Details
-
14.7.2 Company 7 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Company 7 Primary Biliary Cholangitis Therapeutics Product and Service
-
14.8 Company 8
-
14.8.1 Company 8 Company Details
-
14.8.2 Company 8 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Company 8 Primary Biliary Cholangitis Therapeutics Product and Service
-
14.9 Company 9
-
14.9.1 Company 9 Company Details
-
14.9.2 Company 9 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Company 9 Primary Biliary Cholangitis Therapeutics Product and Service
-
14.10 Company 10
-
14.10.1 Company 10 Company Details
-
14.10.2 Company 10 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Company 10 Primary Biliary Cholangitis Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Primary Biliary Cholangitis Therapeutics
-
Figure Primary Biliary Cholangitis Therapeutics Picture
-
Table Global Primary Biliary Cholangitis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Primary Biliary Cholangitis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Primary Biliary Cholangitis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Primary Biliary Cholangitis Therapeutics Consumption by Country (2017-2022)
-
Figure United States Primary Biliary Cholangitis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Primary Biliary Cholangitis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Primary Biliary Cholangitis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Primary Biliary Cholangitis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Primary Biliary Cholangitis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Primary Biliary Cholangitis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Primary Biliary Cholangitis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Primary Biliary Cholangitis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Primary Biliary Cholangitis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Primary Biliary Cholangitis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Primary Biliary Cholangitis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Primary Biliary Cholangitis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Primary Biliary Cholangitis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 3 Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Primary Biliary Cholangitis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Primary Biliary Cholangitis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Company 1 (Foundation Year, Company Profile and etc.)
-
Table Company 1 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 1 Primary Biliary Cholangitis Therapeutics Product and Service
-
Table Company 2 (Foundation Year, Company Profile and etc.)
-
Table Company 2 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 2 Primary Biliary Cholangitis Therapeutics Product and Service
-
Table Company 3 (Foundation Year, Company Profile and etc.)
-
Table Company 3 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 3 Primary Biliary Cholangitis Therapeutics Product and Service
-
Table Company 4 (Foundation Year, Company Profile and etc.)
-
Table Company 4 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 4 Primary Biliary Cholangitis Therapeutics Product and Service
-
Table Company 5 (Foundation Year, Company Profile and etc.)
-
Table Company 5 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 5 Primary Biliary Cholangitis Therapeutics Product and Service
-
Table Company 6 (Foundation Year, Company Profile and etc.)
-
Table Company 6 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 6 Primary Biliary Cholangitis Therapeutics Product and Service
-
Table Company 7 (Foundation Year, Company Profile and etc.)
-
Table Company 7 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 7 Primary Biliary Cholangitis Therapeutics Product and Service
-
Table Company 8 (Foundation Year, Company Profile and etc.)
-
Table Company 8 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 8 Primary Biliary Cholangitis Therapeutics Product and Service
-
Table Company 9 (Foundation Year, Company Profile and etc.)
-
Table Company 9 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 9 Primary Biliary Cholangitis Therapeutics Product and Service
-
Table Company 10 (Foundation Year, Company Profile and etc.)
-
Table Company 10 Primary Biliary Cholangitis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 10 Primary Biliary Cholangitis Therapeutics Product and Service
-
